Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

March 23, 2020
Review

Excision repair of topoisomerase DNA-protein crosslinks (TOP-DPC)

DNA Repair
Yilun SunYves Pommier
August 24, 2017
Open Access

Ancestry as a potential modifier of gene expression in breast tumors from Colombian women

PloS One
Silvia J Serrano-GómezJovanny Zabaleta
May 30, 2020

Epigenetic Mechanisms Underlying Anthracycline-Induced Cardiotoxicity

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
C ChenR Foo
November 25, 2017

Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma

Human Pathology
Radwa El BeheryPatricia Aoun
December 24, 2019

Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition

Journal of Molecular and Cellular Cardiology
Jaewon OhSeok-Min Kang
September 14, 2018
Open Access

Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells

Scientific Reports
Hilal Taymaz-NikerelBetül Kırdar
October 17, 2019
Review
Open Access

Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility

Genes
Naomi D AtkinYuh-Hwa Wang
May 31, 2018
Open Access

Multiple determinants and consequences of cohesion fatigue in mammalian cells

Molecular Biology of the Cell
Hem SapkotaGary J Gorbsky
March 25, 2019
Review
Open Access

Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer

Cancer Science
Michihiko KuwanoMayumi Ono
September 22, 2020

Natural Product as Anti-Cancerous Therapeutic Molecules Targeted towards Topoisomerases

Current Protein & Peptide Science
Swati SinghU N Dwivedi
April 26, 2017
Open Access

Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin

Proceedings of the National Academy of Sciences of the United States of America
Kang LiuWeei-Chin Lin

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

© 2020 Meta ULC. All rights reserved
/feed-previews/anthracycline-sensitivity-chromatin/07242c20-be12-4754-af3c-da6373624e01